D-131-2013 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-131-2013 was initiated by West-Ward Pharmaceutical Corp. on Dec 7, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets. The recall status is terminated (terminated Aug 4, 2014). Affected quantity: 43,075 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 30, 2013
Initiation Date
Dec 7, 2012
Termination Date
Aug 4, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43,075 bottles

Product description

Propylthiouracil Tablets, USP, 50 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1480-01) and b) 1000-count tablets per bottle (NDC 0143-1480-10), Rx only, Manufactured by: West-ward Pharmaceuticals Corp. Eatontown, NJ 07724.

Reason for recall

Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 68478A, 69059A, 69059B, Exp 01/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-131-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-131-2013. Report a data issue: hello@regdatalab.com.